Trial Profile
Survey research on the effects of statin alone or a combination of statin and EPA on endothelial function in patients with type 2 diabetes complicated with dyslipidemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jul 2012
Price :
$35
*
At a glance
- Drugs Ethyl eicosapentaenoic acid (Primary) ; HMG-CoA reductase inhibitors
- Indications Diabetic angiopathies; Dyslipidaemias; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 20 Jun 2011 New trial record